Fresh analysis indicates that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop conventional lifestyle regimens.
Published data in a prominent health publication shows that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Users buying such medications should be aware of the potential of rapid weight regain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment weight in about one and a half years.
Analyzing Therapies
The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of these new drugs with conventional dieting.
Researchers point out that individuals who shed pounds through dieting typically have a more gradual weight regain—around 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Doctors believe the way of the drugs accounts for the amplified weight return.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls appetite.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating much more probable."
An Ongoing Condition?
Health authorities suggest the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Professionals say that, due to the likelihood of weight regain, the treatment should be considered life-long.
This opinion is supported by pharmaceutical companies, who note that the findings "underscore the persistent character of excess weight," akin to managing conditions like hypertension.
User Testimonies
People who have stopped the medication explain a sudden return of appetite.
"It felt as if a trigger that goes on and I was suddenly starving," said one woman.
This challenge is compounded if patients have not established sustainable dietary or behavioural modifications during treatment.
Widespread Adoption
Figures show that millions of people in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is higher among females compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
Ultimately, researchers emphasize that while these medications are effective tools for weight loss, they are not a permanent cure and lasting health benefits relies on ongoing lifestyle support.
